BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/27/2017 10:31:19 AM | Browse: 972 | Download: 1889
 |
Received |
|
2017-06-19 00:45 |
|
Peer-Review Started |
|
2017-06-19 07:25 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2017-07-20 07:54 |
|
Revised |
|
2017-10-15 13:12 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2017-11-14 11:10 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2017-11-20 06:48 |
|
Articles in Press |
|
2017-11-20 06:48 |
|
Edit the Manuscript by Language Editor |
|
2017-11-29 18:35 |
|
Typeset the Manuscript |
|
2017-12-26 01:02 |
|
Publish the Manuscript Online |
|
2017-12-27 10:31 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Primary biliary cholangitis metachronously complicated with combined hepatocellular carcinomacholangiocellular carcinoma and hepatocellular carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ryuta Ide, Akihiko Oshita, Takashi Nishisaka, Hideki Nakahara, Shiomi Aimitsu and Toshiyuki Itamoto |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Akihiko Oshita, MD, PhD, Surgeon, Department of Gastroenterological Surgery, Hiroshima Prefectural Hospital, 1-5-54 Ujina-kanda, Minami-ku, Hiroshima 734-8530, Japan. oshita-akihiko@umin.ac.jp |
| Key Words |
Primary biliary cholangitis; Combined hepatocellular carcinoma and cholangiocellular carcinoma; Hepatocellular carcinoma |
| Core Tip |
Primary biliary cholangitis (PBC) is a progressive cholestatic liver disease characterized by the presence of highly specific antimitochondrial antibodies, portal inflammation and lymphocyte-dominated destruction of the intrahepatic bile ducts, which leads to cirrhosis. While its pathogenesis remains unclear, PBC that shows histological progression to fibrosis carries a high risk of carcinogenesis; the same is true of viral liver diseases. In patients with PBC, the development of hepatocellular carcinoma is rare; the development of combined hepatocellular carcinoma and cholangiocellular carcinoma (cHCC-CCC) is extraordinary. Herein, we report a rare case of PBC metachronously complicated by cHCC-CCC and HCC; which, to the best of our knowledge, has never been reported. |
| Publish Date |
2017-12-27 10:31 |
| Citation |
Ide R, Oshita A, Nishisaka T, Nakahara H, Aimitsu S, Itamoto T. Primary biliary cholangitis metachronously complicated with combined hepatocellular carcinoma-cholangiocellular carcinoma and hepatocellular carcinoma. World J Hepatol 2017; 9(36): 1378-1384 Available from: URL: http://www.wjgnet.com/1948-5182/full/v9/i36/1378.htm DOI: http://dx.doi.org/10.4254/wjh.v9.i36.1378 |
| URL |
http://www.wjgnet.com/1948-5182/full/v9/i36/1378.htm |
| DOI |
http://dx.doi.org/10.4254/wjh.v9.i36.1378 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
